石药创新
(300765)
| 流通市值：541.05亿 | | | 总市值：541.05亿 |
| 流通股本：14.05亿 | | | 总股本：14.05亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 664,646,761.85 | 2,157,680,212.7 | 1,593,014,097.66 | 1,049,557,677.74 |
| 营业总成本 | 793,983,206.85 | 2,768,620,899.67 | 1,914,330,227.48 | 1,261,884,713.55 |
| 其他经营收益 | | | | |
| 营业利润 | -118,486,645.59 | -545,413,074.77 | -261,685,084.87 | -153,801,347.89 |
| 利润总额 | -119,605,425.39 | -551,537,482.86 | -265,571,941.93 | -155,651,301.38 |
| 净利润 | -129,866,337.75 | -609,336,030.7 | -310,248,602.63 | -186,795,363.28 |
| 每股收益 | | | | |
| 其他综合收益 | -2,192,512.84 | 1,766,934.17 | 2,527,609.18 | 3,000,177.76 |
| 综合收益总额 | -132,058,850.59 | -607,569,096.53 | -307,720,993.45 | -183,795,185.52 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,770,000,765.63 | 2,853,148,358.7 | 2,936,662,409.15 | 2,879,936,491.72 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,440,001,467.74 | 3,423,162,933.12 | 3,274,218,229.05 | 3,285,235,083 |
| 资产总计 | 6,210,002,233.37 | 6,276,311,291.82 | 6,210,880,638.2 | 6,165,171,574.72 |
| 流动负债: | | | | |
| 流动负债合计 | 2,772,038,506.08 | 2,709,138,249.22 | 1,902,102,951.3 | 1,745,273,834.49 |
| 非流动负债: | | | | |
| 非流动负债合计 | 767,582,328.4 | 771,906,145.65 | 143,950,512.22 | 127,835,278.74 |
| 负债合计 | 3,539,620,834.48 | 3,481,044,394.87 | 2,046,053,463.52 | 1,873,109,113.23 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,577,035,104.62 | 2,667,343,683.63 | 3,687,757,832.28 | 3,706,913,849.96 |
| 股东权益合计 | 2,670,381,398.89 | 2,795,266,896.95 | 4,164,827,174.68 | 4,292,062,461.49 |
| 负债和股东权益合计 | 6,210,002,233.37 | 6,276,311,291.82 | 6,210,880,638.2 | 6,165,171,574.72 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 504,466,537.44 | 2,527,269,528.26 | 1,531,540,956.53 | 1,164,662,127.89 |
| 经营活动现金流出小计 | 683,986,311.32 | 2,722,962,099.59 | 1,706,662,516.46 | 1,316,468,247.34 |
| 经营活动产生的现金流量净额 | -179,519,773.88 | -195,692,571.33 | -175,121,559.93 | -151,806,119.45 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 386,540,000 | 2,038,875,010.54 | 1,453,980,907.03 | 973,190,499.34 |
| 投资活动现金流出小计 | 457,468,522.92 | 2,377,386,404.91 | 1,698,853,304.43 | 1,166,212,516.51 |
| 投资活动产生的现金流量净额 | -70,928,522.92 | -338,511,394.37 | -244,872,397.4 | -193,022,017.17 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 120,000,000 | 553,204,584.27 | 395,000,000 | 305,000,000 |
| 筹资活动现金流出小计 | 9,533,661.5 | 129,012,708.53 | 54,933,251.68 | 28,507,849.31 |
| 筹资活动产生的现金流量净额 | 110,466,338.5 | 424,191,875.74 | 340,066,748.32 | 276,492,150.69 |
| 汇率变动对现金及现金等价物的影响 | -3,622,231.85 | 20,266,233.7 | 23,766,164.25 | 24,006,142.69 |
| 现金及现金等价物净增加额 | -143,604,190.15 | -89,745,856.26 | -56,161,044.76 | -44,329,843.24 |
| 期末现金及现金等价物余额 | 625,632,646.78 | 769,236,836.93 | 802,821,648.43 | 814,652,849.95 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -89,745,856.26 | - | -44,329,843.24 |